Test Price
2,800 AED✅ Home Collection Available
AGPS Gene Rhizomelic Chondrodysplasia Punctata Type 3 (RCDP3) Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين AGPS (النوع 3 من خلل التنسج الغضروفي المنقط الجذري) في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
الفحص الجيني للكشف عن طفرات جين AGPS باستخدام تقنية التسلسل من الجيل التالي (NGS)، دقة تشخيصية بنسبة 99.9%، خدمة سحب منزلي معتمدة وفق معايير ISO 9001:2015، واستشارة وراثية هاتفية بعد الفحص.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection & VIP Mobile Phlebotomy (8 AM – 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by a DHA-licensed genetic counselor.
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
Clinical Test Overview & Comparative Advantage
The AGPS NGS test analyses the entire coding region of the AGPS gene to detect pathogenic variants associated with Rhizomelic Chondrodysplasia Punctata Type 3 (RCDP3), a severe peroxisomal biogenesis disorder. يقدم هذا الفحص تشخيصًا جزيئيًا دقيقًا للعائلات الإماراتية، مما يتيح استشارة وراثية مبكرة وتخطيطًا عائليًا مستنيرًا.
| Feature | Our Test (Best-in-Class) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Methodology | Next Generation Sequencing (NGS) – full gene coverage | Sanger sequencing of selected exons only |
| Diagnostic Yield | >99% detection of single nucleotide variants & small indels | ~85% (limited by targeted regions) |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
Physician Insight & Clinical Safety Protocol
“As a DHA-licensed Clinical Geneticist, I emphasize that while this NGS test offers unparalleled precision in identifying AGPS gene mutations, results must be interpreted within the broader clinical context and alongside a comprehensive pedigree analysis. Genetic counseling is mandatory to discuss implications for family planning and management. Do not discontinue any prescribed medications without consulting your doctor.”
— Dr. PRABHAKAR REDDY, DHA License No. 61713011, Senior Clinical Geneticist
⚠️ Medication & Safety Warning
Do not discontinue prescribed medication without consulting your doctor.
- Exclusion Criteria for Blood Draw: Active febrile illness, known coagulopathy, platelet count <50,000/µL, or ongoing high-dose anticoagulant therapy (clearance required).
- Minors: Written informed consent from a legal guardian is mandatory per UAE CDS Law (2026).
- Pre-test Requirement: A detailed clinical history and a genetic counselling session to draw a pedigree chart of family members affected with AGPS gene-related conditions.
🚨 Emergency Red Flags – Seek Immediate Medical Attention
- New-onset seizures or unexplained loss of consciousness.
- Apnea (cessation of breathing) or severe respiratory distress.
- Acute exacerbation of joint contractures or skeletal deformities causing immobility.
- Signs of metabolic crisis: severe lethargy, vomiting, hypoglycemia, or hypothermia.
Frequently Asked Questions (Patient & Family Guidance)
Q1: What exactly does the AGPS gene test detect?
Snippet: This test identifies pathogenic DNA variants in the AGPS gene responsible for Rhizomelic Chondrodysplasia Punctata Type 3.
The NGS assay covers the entire coding sequence, detecting point mutations, small deletions/insertions, and copy number variations, providing a definitive molecular diagnosis for dysmorphology evaluation.
يكشف فحص جين AGPS عن الطفرات المسببة لخلل التنسج الغضروفي المنقط الجذري من النوع الثالث بدقة عالية.
Q2: Why is NGS preferred over traditional sequencing for this condition?
Snippet: NGS provides simultaneous, high-depth analysis of all AGPS exons, reducing diagnostic odyssey by weeks.
Traditional Sanger methods often require sequential, exon-by-exon testing, delaying results. Our NGS workflow delivers comprehensive variant detection in a single run, aligned with 2026 diagnostic standards.
تقنية NGS تفحص كامل الجين دفعة واحدة، مما يوفر تشخيصًا أسرع وأكثر شمولاً مقارنة بالطرق التقليدية.
Q3: How long until I receive results, and who will interpret them?
Snippet: Results are ready within 3–4 weeks and include a comprehensive clinical report interpreted by a DHA-licensed geneticist.
A telephonic post-test consultation with a specialist genetic counselor is included to explain findings, inheritance patterns, and family planning options, ensuring full compliance with UAE Federal Decree-Law No. 41 of 2024 (Art. 87).
تظهر النتائج خلال 3–4 أسابيع مع تقرير سريري شامل واستشارة وراثية هاتفية مع أخصائي مرخص من هيئة الصحة بدبي.
Regulatory Compliance & Data Privacy
This adheres to UAE Federal Decree-Law No. 41 of 2024 (Art. 87) on genetic testing, the 2026 CDS Law for minors, and UAE PDPL standards. All sample processing is performed at a facility holding ISO 9001:2015 certification (Cert: INT/EGQ/2509DA/3139), ensuring globally recognized quality management. Patient genomic data is stored and transmitted using encrypted, DHA‑approved protocols.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians